Blog Read the latest perspectives from our team of subject matter experts and others How H1 Is Solving the Data Accuracy Problem for Health PlansHealth plans face a persistent challenge: inaccurate, incomplete, and constantly changing provider data that puts compliance at risk and frustrates your members. H1 partners with health plans across the country… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Drug Development Global Impact KOL Engagement Patient Representation Provider Data Post Industries:Digital Health Health Plans Pharmaceutical & Biotechnology Drug DevelopmentPatient Representation3 Common Questions Related to Clinical Trial Performance DataOver the past decade, the cost and time impact to bring drugs to market have been increasing. With the recent trends in healthcare (more inclusion for both patients as well… Continue reading → Read the articleno CommercializationUnlocking Value-Based Care: How Pharma & MedTech Companies Can Thrive in a New Age of Private Payers and Population HealthAs the healthcare industry shifts to value-based care, private payers and population health are taking the lead in determining patient care. For pharma and med tech companies, this shift… Continue reading → Read the articleno CommercializationDrug DevelopmentKOL EngagementPatient RepresentationProvider DataH1 Honored with a Spot on Y Combinator’s 2023 Best Companies List and Slice of Healthcare’s Inaugural Digital Health Leaders ListH1, the connecting force for global healthcare provider, clinical, science, and research information, today announced that it has been recognized in two prestigious annual lists: Y Combinator’s 2023 Best Companies… Continue reading → Read the articleno CommercializationKOL EngagementMedical Public Awareness Campaigns—Examples and EffectivenessMedical public awareness campaigns are designed to distribute important healthcare messages to large populations. With over seven billion people in the world, it is necessary to find ways to share… Continue reading → Read the article Drug DevelopmentPatient RepresentationBest-Fit Sites for Clinical TrialsWhen evaluating the feasibility of a clinical trial, it’s essential to consider what success means. This can mean defining criteria for your patient population, principal investigator (PI) qualifications, and… Continue reading → Read the articleno Patient RepresentationHow to Build a Scalable Patient Representation StrategyPut simply – in 2022, clinical trial diversity, equity and inclusion (DEI) was top of mind for the pharma and biotech industries, across all phases of drug and device… Continue reading → Read the articleno«‹78910111213›»
